Download Files:
Tabimorelin (hemifumarate)
SKU
HY-103540-Get quote
Category Reference compound
Tags Cytochrome P450, Endocrinology, Metabolic Enzyme/Protease
Products Details
Product Description
– Tabimorelin (NN703) hemifumarate is an orally active growth hormone (GH) secretagogue. Tabimorelin hemifumarate is also a potent inhibitor of CYP3A4 activity[1].
Web ID
– HY-103540
Shipping
– Room temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C32H40N4O3.1/2C4H4O4
References
– [1]Zdravkovic M, et al. A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate. Eur J Clin Pharmacol. 2003 Feb;58(10):683-8.
CAS Number
– 242143-80-2
Molecular Weight
– 586.72
SMILES
– CNC([C@@H](CC1=CC=CC=C1)N(C)C([C@H](N(C)C(/C=C/CC(C)(N)C)=O)CC2=CC3=CC=CC=C3C=C2)=O)=O.OC(/C=C/C(O)=O)=O
Clinical Information
– No Development Reported
Research Area
– Endocrinology
Solubility
– 10 mM in DMSO
Target
– Cytochrome P450
Isoform
– CYP3
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.